BioSpace News Archive

Aarskog syndrome is a rare genetic condition leading to short stature, multiple facial, other limb & genital abnormalities. Aarskog syndrome majorly affects males, and clinical symptoms vary on a case-to-case basis.

Lassa fever is a type of acute illness caused by a single-stranded RNA arena virus, which belongs to the family Arenaviridae.

Polyphosphoric acids (PPA) are reactive oligomers having a short-chain polymer. These inorganic chemicals are odorless, colorless, highly viscous liquids and possess strong hygroscopic properties.

Researchers in the axial spondyloarthritis treatment sector are leveraging radiographic treatments and awareness about inflammatory back pain for development of long-term solutions.

Investments towards research for lifestyle-associated and infectious respiratory ailments supports the widened scope of applications for capnography devices.

Rapid adoption of advanced technology and increasing research & development activities are spurring sales

The healthcare regulatory affairs outsourcing market is experiencing significant growth owing to services to Clinical Research Organizations.

The cell therapy technologies market is expected to gain immense growth opportunities through the forecast period of 2019-2029 owing to the rising influence of cell therapies across the life sciences sector.

The global analytical standards market provides increasing public concerns related to optimum food quality and safety, increasing applications of different analytical techniques in proteomics & metabolomics, and better regulatory emphasis on efficient pollution control and monitoring are some of the important factors driving the growth of the analytical standards market.

PsiOxus Therapeutics, Ltd. announced an updated agreement to advance its clinical collaboration with Bristol Myers Squibb to evaluate the safety, tolerability, and preliminary efficacy of PsiOxus’ tumor re-engineering platform, in combination with Bristol Myers Squibb’s PD-1 immune checkpoint inhibitor Opdivo® to treat a range of tumor types in late-stage cancer patients.